# US 2010/0169022 A1 · Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0169022 A1
- Document ID: US20100169022A1
- Status: Published application
- Kind: A1
- Application number: 12/319,153
- Filed: 2008-12-30
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: Searete LLC, a limited liability corporation of the State of Delaware
- Inventors: Mahalaxmi Gita Bangera; Roderick A. Hyde; Muriel Y. Ishikawa; Elizabeth A. Sweeney; Lowell L. Wood, JR.; Victoria Y.H. Wood
- Web page: https://patentgrep.com/patent/US20100169022A1

## CPC

- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Methods and systems such as those described herein include accepting input, identifying CYP450-family enzymes, identifying at least one modulator of an enzyme, and communicating one or more treatments to a system user.

## Claims

### Claim 1

A method comprising:
accepting input that specifies an individual;
accepting input that specifies at least one environmental exposure of the individual;
identifying at least one toxin associated with the at least one environmental exposure;
identifying at least one CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
identifying at least one modulator of one or more of the at least one CYP450-family enzyme; and
invoking circuitry for communicating one or more treatment to a system user, wherein the one or more treatment includes the at least one modulator of one or more of the at least one CYP450-family enzyme.

### Claim at position 2

2-12. (canceled)

### Claim 13 (depends on 1)

The method of claim 1, comprising:
accepting input identifying at least one variant of the at least one CYP450-family enzyme;
identifying at least one modulator of the at least one variant; and
invoking circuitry for communicating the one or more treatment to the at least one system user, wherein the one or more treatment includes one or more of the at least one modulator of the at least one variant.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The method of claim 1, comprising:
accepting input identifying at least one variant of at least one CYP450-family gene;
identifying at least one modulator of the at least one variant CYP450-family gene; and
invoking circuitry for communicating the one or more treatment to the at least one system user, wherein the one or more treatment includes one or more of the at least one modulator of the at least one variant CYP450-family gene.

### Claim 16

(canceled)

### Claim 17 (depends on 1)

The method of claim 1, comprising:
identifying at least one additional CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
identifying at least one modulator of one or more of the at least one additional CYP450-family enzyme; and
invoking circuitry for communicating the one or more treatment for the individual to the at least one system user, wherein the one or more treatment includes both the at least one modulator of one or more of the at least one CYP450-family enzyme and the at least one modulator of one or more of the at least one additional CYP450-family enzyme.

### Claim 18 (depends on 1)

The method of claim 1, comprising:
identifying at least one additional CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
accepting input regarding at least one variant of the at least one additional CYP450-family enzyme associated with the individual;
identifying at least one modulator of one or more of the at least one variant of the at least one additional CYP450-family enzyme; and
invoking circuitry for suggesting the one or more treatment to the at least one system user, wherein the one or more treatment includes both the at least one modulator of one or more of the at least one CYP450-family enzyme and the at least one modulator of one or more of the at least one variant of the at least one additional CYP450-family enzyme.

### Claim 19 (depends on 1)

The method of claim 1, comprising:
invoking circuitry for suggesting one or more dosages of the one or more treatment to the system user;
identifying at least one environmental factor associated with an alteration in activity of at least one of the one or more treatment; and
invoking circuitry for communicating one or more alternate dosages of the one or more treatment to the at least one system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of at least one of the one or more treatment.

### Claim 20 (depends on 19)

The method of claim 19, wherein the at least one environmental factor is associated with the individual.

### Claim 21 (depends on 1)

The method of claim 1, comprising:
invoking circuitry for suggesting one or more dosages of the one or more treatment to the system user;
identifying at least one dietary factor associated with an alteration in activity of at least one of the one or more treatment; and
invoking circuitry for communicating one or more alternate dosages of the one or more treatment to the at least one system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of at least one of the one or more treatment.

### Claim 22 (depends on 21)

The method of claim 21, wherein the at least one dietary factor is associated with the individual.

### Claim 23 (depends on 1)

The method of claim 1, comprising:
associating at least one anatomic location with predicted activity of the at least one CYP450-family enzyme;
associating the at least one anatomic location with one or more of the at least one modulator of one or more of the at least one CYP450-family enzyme; and
invoking circuitry for communicating the one or more treatment to the system user, wherein the one or more treatment includes the at least one modulator of one or more of the at least one CYP450-family enzyme associated with the at least one anatomic location.

### Claim 24

A system comprising:
circuitry for accepting input that specifies an individual;
circuitry for accepting input that specifies at least one environmental exposure of the individual;
circuitry for identifying at least one toxin associated with the at least one environmental exposure;
circuitry for identifying at least one CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
circuitry for identifying at least one modulator of one or more of the at least one CYP450-family enzyme; and
circuitry for communicating one or more treatment to a system user, wherein the one or more treatment includes the at least one modulator of one or more of the at least one CYP450-family enzyme.

### Claim at position 15

25-35. (canceled)

### Claim 36 (depends on 24)

The system of claim 24, comprising:
circuitry for accepting input identifying at least one variant of the at least one CYP450-family enzyme;
circuitry for identifying at least one modulator of the at least one variant; and
circuitry for communicating the one or more treatment to the at least one system user, wherein the one or more treatment includes one or more of the at least one modulator of the at least one variant.

### Claim 37

(canceled)

### Claim 38 (depends on 24)

The system of claim 24, comprising:
circuitry for accepting input identifying at least one variant of at least one CYP450-family gene;
circuitry for identifying at least one modulator of the at least one variant of the at least one CYP450-family gene; and
circuitry for communicating the one or more treatment to the at least one system user, wherein the one or more treatment includes one or more of the at least one modulator of the at least one variant.

### Claim 39

(canceled)

### Claim 40 (depends on 24)

The system of claim 24, comprising:
circuitry for identifying at least one additional CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
circuitry for identifying at least one modulator of one or more of the at least one additional CYP450-family enzyme; and
circuitry for communicating the one or more treatment for the individual to the at least one system user, wherein the one or more treatment includes both the at least one modulator of the at least one CYP450-family enzyme and the at least one modulator of the at least one additional CYP450-family enzyme.

### Claim 41 (depends on 24)

The system of claim 24, comprising:
circuitry for identifying at least one additional CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
circuitry for accepting input regarding at least one variant of the at least one additional CYP450-family enzyme associated with the individual;
circuitry for identifying at least one modulator of one or more of the at least one variant of the at least one additional CYP450-family enzyme; and
circuitry for suggesting the one or more treatment to the at least one system user, wherein the one or more treatment includes both the at least one modulator of the at least one CYP450-family enzyme and the at least one modulator of the at least one variant of the at least one additional CYP450-family enzyme.

### Claim 42 (depends on 24)

The system of claim 24, comprising:
circuitry for suggesting one or more dosages of the one or more treatment to the system user;
circuitry for identifying at least one environmental factor associated with an alteration in activity of at least one of the one or more treatment; and
circuitry for communicating one or more alternate dosages of the one or more treatment to the at least one system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of at least one of the one or more treatment.

### Claim 43 (depends on 42)

The system of claim 42, wherein the at least one environmental factor is associated with the individual.

### Claim 44 (depends on 24)

The system of claim 24, comprising:
circuitry for suggesting one or more dosages of the one or more treatment to the system user;
circuitry for identifying at least one dietary factor associated with an alteration in activity of at least one of the one or more treatment; and
circuitry for communicating one or more alternate dosages of the one or more treatment to the at least one system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of at least one of the one or more treatment.

### Claim 45 (depends on 44)

The system of claim 44, wherein the at least one dietary factor is associated with the individual.

### Claim 46 (depends on 24)

The system of claim 24, comprising:
circuitry for associating at least one anatomic location with predicted activity of the at least one CYP450-family enzyme;
circuitry for associating the at least one anatomic location with one or more of the at least one modulator; and
circuitry for communicating the one or more treatment to the system user, wherein the one or more treatment includes the at least one modulator of one or more of the at least one CYP450-family enzyme associated with the at least one anatomic location.

### Claim 47

A method, comprising:
accepting input relating to microbial infection associated with an individual;
identifying at least one statin therapy, wherein the at least one statin therapy is associated with a reduction in the microbial infection;
identifying at least one CYP450-family enzyme, wherein the at least one CYP450-family enzyme is associated with metabolism of the at least one statin therapy;
identifying at least one modulator of the at least one CYP450-family enzyme; and
invoking circuitry for communicating at least one treatment to a system user, wherein the at least one treatment includes the at least one statin therapy and the at least one modulator.

### Claim at position 28

48-58. (canceled)

### Claim 59 (depends on 47)

The method of claim 47, comprising:
invoking circuitry for suggesting one or more dosages of the at least one treatment to the system user;
identifying at least one environmental factor associated with an alteration in activity of the at least one treatment; and
invoking circuitry for communicating one or more alternate dosages of the at least one treatment to the system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of the at least one treatment.

### Claim 60 (depends on 47)

The method of claim 47, comprising:
invoking circuitry for suggesting one or more dosages of the at least one treatment to the system user;
identifying at least one dietary factor associated with an alteration in activity of the at least one treatment; and
invoking circuitry for communicating one or more alternate dosages of the at least one treatment to the system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of the at least one treatment.

### Claim 61

(canceled)

### Claim 62 (depends on 47)

The method of claim 47, comprising:
accepting input regarding at least one variant of the at least one CYP450-family enzyme associated with the individual;
identifying at least one modulator of the at least one variant of the at least one CYP450-family enzyme; and
invoking circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes one or more of the at least one statin therapy and the at least one modulator of the at least one variant of the at least one CYP450-family enzyme.

### Claim 63

(canceled)

### Claim 64 (depends on 47)

The method of claim 47, comprising:
accepting input regarding at least one variant of the at least one CYP450-family gene associated with the individual;
identifying at least one modulator of the at least one variant of the at least one CYP450-family gene; and
invoking circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes one or more of the at least one statin therapy and the at least one modulator of the at least one variant of the at least one CYP450-family gene.

### Claim 65

(canceled)

### Claim 66 (depends on 47)

The method of claim 47, comprising:
identifying at least one environmental factor associated with activity of the at least one CYP450-family enzyme;
requesting information regarding one or more of the at least one environmental factor in relation to the individual to be treated; and
invoking circuitry for communicating at least one environmental mitigation strategy to the system user.

### Claim 67 (depends on 64)

The method of claim 64, wherein the at least one environmental factor is associated with the individual.

### Claim 68 (depends on 47)

The method of claim 47, comprising:
identifying at least one dietary factor associated with activity of the at least one CYP450-family enzyme;
requesting information regarding one or more of the at least one dietary factor in relation to the individual to be treated; and
invoking circuitry for communicating at least one dietary mitigation strategy to the system user.

### Claim 69 (depends on 68)

The method of claim 68, wherein the at least one dietary factor is associated with the individual.

### Claim 70 (depends on 47)

The method of claim 47, comprising:
associating at least one anatomic location with predicted activity of the at least one CYP450-family enzyme;
associating the at least one anatomic location with one or more of the at least one modulator; and
invoking circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes the at least one modulator of the at least one CYP450-family enzyme associated with the at least one anatomic location.

### Claim 71

A system, comprising:
circuitry for accepting input relating to microbial infection associated with an individual;
circuitry for identifying at least one statin therapy, wherein the at least one statin therapy is associated with a reduction in the microbial infection;
circuitry for identifying at least one CYP450-family enzyme, wherein the at least one CYP450-family enzyme is associated with metabolism of the at least one statin therapy;
circuitry for identifying at least one modulator of the at least one CYP450-family enzyme; and
circuitry for communicating at least one treatment to a system user, wherein the at least one treatment includes the at least one statin therapy and the at least one modulator.

### Claim at position 42

72-82. (canceled)

### Claim 83 (depends on 71)

The system of claim 71, comprising:
circuitry for suggesting one or more dosages of the at least one treatment to the system user;
circuitry for identifying at least one environmental factor associated with an alteration in activity of the at least one treatment; and
circuitry for communicating one or more alternate dosages of the at least one treatment to the system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of the at least one treatment.

### Claim 84 (depends on 71)

The system of claim 71, comprising:
circuitry for suggesting one or more dosages of the at least one treatment to the system user;
circuitry for identifying at least one dietary factor associated with an alteration in activity of the at least one treatment; and
circuitry for communicating one or more alternate dosages of the at least one treatment to the system user, wherein the one or more alternate dosages are calculated to compensate for the alteration in activity of at least one of the at least one treatment.

### Claim 85

(canceled)

### Claim 86 (depends on 71)

The system of claim 71, comprising:
circuitry for accepting input regarding at least one variant of the at least one CYP450-family enzyme associated with the individual;
circuitry for identifying at least one modulator of the at least one variant of the at least one CYP450-family enzyme; and
circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes one or more of the at least one statin therapy and the at least one modulator of the at least one variant of the at least one CYP450-family enzyme.

### Claim 87

(canceled)

### Claim 88 (depends on 71)

The system of claim 71, comprising:
circuitry for accepting input regarding at least one variant of the at least one CYP450-family gene associated with the individual;
circuitry for identifying at least one modulator of the at least one variant of the at least one CYP450-family gene; and
circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes one or more of the at least one statin therapy and the at least one modulator of the at least one variant of the at least one CYP450-family gene.

### Claim 89

(canceled)

### Claim 90 (depends on 71)

The system of claim 71, comprising:
circuitry for identifying at least one environmental factor associated with activity of the at least one CYP450-family enzyme;
circuitry for requesting information regarding one or more of the at least one environmental factor in relation to the individual to be treated; and
circuitry for communicating at least one environmental mitigation strategy to the system user.

### Claim 91 (depends on 88)

The system of claim 88, wherein the at least one environmental factor is associated with the individual.

### Claim 92 (depends on 71)

The system of claim 71, comprising:
circuitry for identifying at least one dietary factor associated with activity of the at least one CYP450-family enzyme;
circuitry for requesting information regarding one or more of the at least one dietary factor in relation to the individual to be treated; and
circuitry for communicating at least one dietary mitigation strategy to the system user.

### Claim 93 (depends on 92)

The system of claim 92, wherein the at least one dietary factor is associated with the individual.

### Claim 94 (depends on 71)

The system of claim 71, comprising:
associating at least one anatomic location with predicted activity of the at least one CYP450-family enzyme;
associating the at least one anatomic location with one or more of the at least one modulator; and
invoking circuitry for communicating the at least one treatment to the system user, wherein the at least one treatment includes the at least one modulator of the at least one CYP450-family enzyme associated with the at least one anatomic location.

### Claim 95

A system comprising:
at least one computer program for use with at least one computer system and wherein the at least one computer program includes a plurality of instructions including but not limited to:
one or more instructions for accepting input that specifies an individual;
one or more instructions for accepting input that specifies at least one environmental exposure of the individual;
one or more instructions for identifying at least one toxin associated with the at least one environmental exposure;
one or more instructions for identifying at least one CYP450-family enzyme associated with metabolism of one or more of the at least one toxin;
one or more instructions for identifying at least one modulator of one or more of the at least one CYP450-family enzyme; and
one or more instructions for communicating one or more treatment to a system user, wherein the one or more treatment includes the at least one modulator of one or more of the at least one CYP450-family enzyme.

### Claim 96

A system, comprising:
at least one computer program for use with at least one computer system and wherein the at least one computer program includes a plurality of instructions including but not limited to:
one or more instructions for accepting input relating to microbial infection associated with an individual;
one or more instructions for identifying at least one statin therapy, wherein the at least one statin therapy is associated with a reduction in the microbial infection;
one or more instructions for identifying at least one CYP450-family enzyme, wherein the at least one CYP450-family enzyme is associated with metabolism of the at least one statin therapy;
one or more instructions for identifying at least one modulator of the at least one CYP450-family enzyme; and
one or more instructions for communicating at least one treatment to a system user, wherein the at least one treatment includes the at least one statin therapy and the at least one modulator.
